United States Biotechnology & Medical Research

Biohaven Pharmaceutical Holding Company Ltd (BHVN)

Track

Biohaven Pharmaceutical Holding Company Ltd has seen no insider trading activity within the last three months. The most recent recorded transaction occurred on August 19, 2022, involving a purchase of shares. Prior historical data reflects various planned sales by company executives throughout late 2021 and early 2022.
Ticker: BHVN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Bailey Gregory Non-Executive Director
Transaction date
Purchase
Price
378.42
Quantity 58,986 -20.3%
Value US$4,839,649
3.2
Clark George C. VP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
20.59
Quantity 82,588 +39.2%
Value US$499,660
3.2
Clark George C. VP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
216.15
Quantity 86,958 -49.3%
Value US$1,353,717
3.2
Clark George C. VP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
118.05
Quantity 500 -5.0%
Value US$59,024
3.2
Clark George C. VP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
116.02
Quantity 2,159 -17.7%
Value US$250,485
3.2
Clark George C. VP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
114.93
Quantity 3,196 -20.8%
Value US$367,314
2.4
GREGORY JULIA P Non-Executive Director
Transaction date
Planned sale
Price
125.00
Quantity 12,000 -100.0%
Value US$1,500,000
3.2
Clark George C. VP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
123.84
Quantity 1,915 -18.9%
Value US$237,154
Stock Elyse Chief Medical Officer Officer
Transaction date
Planned sale
Price
106.17
Quantity 1,589 -17.5%
Value US$168,701
Stock Elyse Chief Medical Officer Officer
Transaction date
Planned sale
Price
105.43
Quantity 20,330 -69.2%
Value US$2,143,426
Stock Elyse Chief Medical Officer Officer
Transaction date
Planned sale
Price
105.02
Quantity 6,939 -48.2%
Value US$728,762
0.5
Engelhart James Chief Financial Officer Officer
Transaction date
Planned sale
Price
103.85
Quantity 1,382 -11.0%
Value US$143,516
0.5
Engelhart James Chief Financial Officer Officer
Transaction date
Planned sale
Price
102.70
Quantity 23,487 -65.1%
Value US$2,412,162
0.5
Engelhart James Chief Financial Officer Officer
Transaction date
Planned sale
Price
102.01
Quantity 10,131 -21.9%
Value US$1,033,467
3.7
Doogan Declan Non-Executive Director
Transaction date
Sale
Price
113.25
Quantity 11,499 -1.3%
Value US$1,302,316
3.7
Doogan Declan Non-Executive Director
Transaction date
Sale
Price
112.40
Quantity 13,026 -1.5%
Value US$1,464,117
3.7
Doogan Declan Non-Executive Director
Transaction date
Sale
Price
117.87
Quantity 7,073 -0.8%
Value US$833,711
3.7
Doogan Declan Non-Executive Director
Transaction date
Sale
Price
116.69
Quantity 18,230 -2.0%
Value US$2,127,173
3.7
Doogan Declan Non-Executive Director
Transaction date
Sale
Price
115.90
Quantity 12,437 -1.3%
Value US$1,441,501
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
123.30
Quantity 1,110 +0.0%
Value US$136,862
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
122.75
Quantity 3,890 +0.2%
Value US$477,480
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
76.00
Quantity 13,157 +0.5%
Value US$999,932
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
85.14
Quantity 10,000 +0.4%
Value US$851,370
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
89.55
Quantity 5,000 +0.2%
Value US$447,736
JONES WILLIAM A JR CCO-Migraine & Common Disease Officer
Transaction date
Planned sale
Price
77.70
Quantity 1,300 -42.6%
Value US$101,005
JONES WILLIAM A JR CCO-Migraine & Common Disease Officer
Transaction date
Planned sale
Price
77.01
Quantity 4,010 -56.8%
Value US$308,799
JONES WILLIAM A JR CCO-Migraine & Common Disease Officer
Transaction date
Planned sale
Price
76.02
Quantity 24,690 -77.8%
Value US$1,876,872
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
79.94
Quantity 212 -0.0%
Value US$16,948
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
78.89
Quantity 10,191 -0.4%
Value US$803,918
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
79.88
Quantity 3,100 -0.1%
Value US$247,632
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
79.41
Quantity 21,466 -0.8%
Value US$1,704,720
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
78.98
Quantity 4,554 -0.2%
Value US$359,655
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
78.88
Quantity 3,748 -0.1%
Value US$295,638
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
78.87
Quantity 6,729 -0.3%
Value US$530,740
Gentile Kimberly SVP, Clinical Operations Officer
Transaction date
Planned sale
Price
77.42
Quantity 2,458 -40.3%
Value US$190,300
Gentile Kimberly SVP, Clinical Operations Officer
Transaction date
Planned sale
Price
76.42
Quantity 15,781 -72.1%
Value US$1,205,938
Gentile Kimberly SVP, Clinical Operations Officer
Transaction date
Planned sale
Price
75.62
Quantity 5,261 -19.4%
Value US$397,844
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
59.25
Quantity 3,322 +0.1%
Value US$196,828
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
59.00
Quantity 6,678 +0.3%
Value US$393,984
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
61.87
Quantity 15,129 +0.6%
Value US$936,093
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
61.28
Quantity 7,271 +0.3%
Value US$445,568
4.2
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
60.32
Quantity 2,600 +0.1%
Value US$156,824
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
75.93
Quantity 5,991 -0.2%
Value US$454,888
0.5
Berman Robert Special Projects & Med Ovrsght Officer
Transaction date
Planned sale
Price
75.29
Quantity 2,778 -89.1%
Value US$209,145
0.5
Berman Robert Special Projects & Med Ovrsght Officer
Transaction date
Planned sale
Price
75.25
Quantity 55,626 -94.7%
Value US$4,185,745
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
75.12
Quantity 44,009 -1.7%
Value US$3,305,877
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
70.24
Quantity 2,395 -0.1%
Value US$168,225
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
69.29
Quantity 1,600 -0.1%
Value US$110,865
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
75.18
Quantity 835 -0.0%
Value US$62,779
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
74.60
Quantity 63,257 -2.3%
Value US$4,719,257
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
73.72
Quantity 24,084 -0.9%
Value US$1,775,369
0.5
Berman Robert Special Projects & Med Ovrsght Officer
Transaction date
Planned sale
Price
75.05
Quantity 4,296 -92.6%
Value US$322,431
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
72.70
Quantity 13,467 -0.5%
Value US$979,027
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
73.64
Quantity 49,132 -1.8%
Value US$3,618,012
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
72.91
Quantity 20,659 -0.7%
Value US$1,506,202
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
72.01
Quantity 10,540 -0.4%
Value US$758,961
0.5
Berman Robert Special Projects & Med Ovrsght Officer
Transaction date
Planned sale
Price
75.07
Quantity 986 -74.3%
Value US$74,016
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
75.22
Quantity 428 -0.0%
Value US$32,193
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
73.78
Quantity 22,584 -0.8%
Value US$1,666,268
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
72.93
Quantity 12,157 -0.4%
Value US$886,619
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
71.98
Quantity 21,798 -0.8%
Value US$1,568,935
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
70.91
Quantity 58,238 -2.0%
Value US$4,129,855
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
70.10
Quantity 26,814 -0.9%
Value US$1,879,793
3.7
Bailey Gregory Non-Executive Director
Transaction date
Planned sale
Price
69.01
Quantity 22,012 -0.7%
Value US$1,519,094
0.5
Berman Robert Special Projects & Med Ovrsght Officer
Transaction date
Planned sale
Price
76.05
Quantity 1,400 -80.4%
Value US$106,467
0.5
Berman Robert Special Projects & Med Ovrsght Officer
Transaction date
Planned sale
Price
75.25
Quantity 59,914 -97.2%
Value US$4,508,822
Gentile Kimberly SVP, Clinical Operations Officer
Transaction date
Planned sale
Price
70.20
Quantity 400 -9.9%
Value US$28,081
Gentile Kimberly SVP, Clinical Operations Officer
Transaction date
Planned sale
Price
70.20
Quantity 24,000 -86.8%
Value US$1,684,870
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
69.42
Quantity 300 -0.0%
Value US$20,825
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
68.73
Quantity 25,208 -3.9%
Value US$1,732,458
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
67.90
Quantity 31,920 -4.7%
Value US$2,167,515
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
66.94
Quantity 2,572 -0.4%
Value US$172,162
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
68.10
Quantity 15,797 -2.3%
Value US$1,075,801
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
67.51
Quantity 18,703 -2.6%
Value US$1,262,557
3.7
Doogan Declan Non-Executive Director
Transaction date
Planned sale
Price
66.05
Quantity 34,336 -4.5%
Value US$2,267,872
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-22 2022-08-19 B Purchase
3.7
Bailey Gregory
Non-Executive Director
58,986 -20.3%
378.42
US$4,839,649 		58,986 -20.3% 378.42 US$4,839,649
2022-05-12 2022-05-10 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
82,588 +39.2%
20.59
US$499,660 		82,588 +39.2% 20.59 US$499,660
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
86,958 -49.3%
216.15
US$1,353,717 		86,958 -49.3% 216.15 US$1,353,717
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
500 -5.0%
118.05
US$59,024 		500 -5.0% 118.05 US$59,024
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
2,159 -17.7%
116.02
US$250,485 		2,159 -17.7% 116.02 US$250,485
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
3,196 -20.8%
114.93
US$367,314 		3,196 -20.8% 114.93 US$367,314
2021-12-22 2021-12-20 PlS Planned sale
2.4
GREGORY JULIA P
Non-Executive Director
12,000 -100.0%
125.00
US$1,500,000 		12,000 -100.0% 125.00 US$1,500,000
2021-12-22 2021-12-20 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
1,915 -18.9%
123.84
US$237,154 		1,915 -18.9% 123.84 US$237,154
2021-12-16 2021-12-15 PlS Planned sale
Stock Elyse

Chief Medical Officer

Officer
1,589 -17.5%
106.17
US$168,701 		1,589 -17.5% 106.17 US$168,701
2021-12-16 2021-12-15 PlS Planned sale
Stock Elyse

Chief Medical Officer

Officer
20,330 -69.2%
105.43
US$2,143,426 		20,330 -69.2% 105.43 US$2,143,426
2021-12-16 2021-12-14 PlS Planned sale
Stock Elyse

Chief Medical Officer

Officer
6,939 -48.2%
105.02
US$728,762 		6,939 -48.2% 105.02 US$728,762
2021-12-10 2021-12-10 PlS Planned sale
0.5
Engelhart James

Chief Financial Officer

Officer
1,382 -11.0%
103.85
US$143,516 		1,382 -11.0% 103.85 US$143,516
2021-12-10 2021-12-10 PlS Planned sale
0.5
Engelhart James

Chief Financial Officer

Officer
23,487 -65.1%
102.70
US$2,412,162 		23,487 -65.1% 102.70 US$2,412,162
2021-12-10 2021-12-10 PlS Planned sale
0.5
Engelhart James

Chief Financial Officer

Officer
10,131 -21.9%
102.01
US$1,033,467 		10,131 -21.9% 102.01 US$1,033,467
2021-12-01 2021-11-29 S Sale
3.7
Doogan Declan
Non-Executive Director
11,499 -1.3%
113.25
US$1,302,316 		11,499 -1.3% 113.25 US$1,302,316
2021-12-01 2021-11-29 S Sale
3.7
Doogan Declan
Non-Executive Director
13,026 -1.5%
112.40
US$1,464,117 		13,026 -1.5% 112.40 US$1,464,117
2021-11-17 2021-11-16 S Sale
3.7
Doogan Declan
Non-Executive Director
7,073 -0.8%
117.87
US$833,711 		7,073 -0.8% 117.87 US$833,711
2021-11-17 2021-11-16 S Sale
3.7
Doogan Declan
Non-Executive Director
18,230 -2.0%
116.69
US$2,127,173 		18,230 -2.0% 116.69 US$2,127,173
2021-11-17 2021-11-16 S Sale
3.7
Doogan Declan
Non-Executive Director
12,437 -1.3%
115.90
US$1,441,501 		12,437 -1.3% 115.90 US$1,441,501
2021-11-10 2021-11-10 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
1,110 +0.0%
123.30
US$136,862 		1,110 +0.0% 123.30 US$136,862
2021-11-10 2021-11-10 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,890 +0.2%
122.75
US$477,480 		3,890 +0.2% 122.75 US$477,480
2021-03-17 2021-03-17 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
13,157 +0.5%
76.00
US$999,932 		13,157 +0.5% 76.00 US$999,932
2021-03-03 2021-03-02 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
10,000 +0.4%
85.14
US$851,370 		10,000 +0.4% 85.14 US$851,370
2020-11-23 2020-11-23 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
5,000 +0.2%
89.55
US$447,736 		5,000 +0.2% 89.55 US$447,736
2020-11-04 2020-11-02 PlS Planned sale
JONES WILLIAM A JR

CCO-Migraine & Common Disease

Officer
1,300 -42.6%
77.70
US$101,005 		1,300 -42.6% 77.70 US$101,005
2020-11-04 2020-11-02 PlS Planned sale
JONES WILLIAM A JR

CCO-Migraine & Common Disease

Officer
4,010 -56.8%
77.01
US$308,799 		4,010 -56.8% 77.01 US$308,799
2020-11-04 2020-11-02 PlS Planned sale
JONES WILLIAM A JR

CCO-Migraine & Common Disease

Officer
24,690 -77.8%
76.02
US$1,876,872 		24,690 -77.8% 76.02 US$1,876,872
2020-10-23 2020-10-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
212 -0.0%
79.94
US$16,948 		212 -0.0% 79.94 US$16,948
2020-10-23 2020-10-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
10,191 -0.4%
78.89
US$803,918 		10,191 -0.4% 78.89 US$803,918
2020-10-23 2020-10-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
3,100 -0.1%
79.88
US$247,632 		3,100 -0.1% 79.88 US$247,632
2020-10-23 2020-10-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
21,466 -0.8%
79.41
US$1,704,720 		21,466 -0.8% 79.41 US$1,704,720
2020-10-21 2020-10-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
4,554 -0.2%
78.98
US$359,655 		4,554 -0.2% 78.98 US$359,655
2020-10-21 2020-10-16 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
3,748 -0.1%
78.88
US$295,638 		3,748 -0.1% 78.88 US$295,638
2020-10-14 2020-10-12 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
6,729 -0.3%
78.87
US$530,740 		6,729 -0.3% 78.87 US$530,740
2020-10-09 2020-10-08 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
2,458 -40.3%
77.42
US$190,300 		2,458 -40.3% 77.42 US$190,300
2020-10-09 2020-10-08 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
15,781 -72.1%
76.42
US$1,205,938 		15,781 -72.1% 76.42 US$1,205,938
2020-10-09 2020-10-08 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
5,261 -19.4%
75.62
US$397,844 		5,261 -19.4% 75.62 US$397,844
2020-09-22 2020-09-21 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,322 +0.1%
59.25
US$196,828 		3,322 +0.1% 59.25 US$196,828
2020-09-14 2020-09-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
6,678 +0.3%
59.00
US$393,984 		6,678 +0.3% 59.00 US$393,984
2020-08-12 2020-08-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
15,129 +0.6%
61.87
US$936,093 		15,129 +0.6% 61.87 US$936,093
2020-08-12 2020-08-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
7,271 +0.3%
61.28
US$445,568 		7,271 +0.3% 61.28 US$445,568
2020-08-12 2020-08-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
2,600 +0.1%
60.32
US$156,824 		2,600 +0.1% 60.32 US$156,824
2020-07-10 2020-07-08 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
5,991 -0.2%
75.93
US$454,888 		5,991 -0.2% 75.93 US$454,888
2020-07-10 2020-07-08 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
2,778 -89.1%
75.29
US$209,145 		2,778 -89.1% 75.29 US$209,145
2020-07-10 2020-07-08 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
55,626 -94.7%
75.25
US$4,185,745 		55,626 -94.7% 75.25 US$4,185,745
2020-07-10 2020-07-08 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
44,009 -1.7%
75.12
US$3,305,877 		44,009 -1.7% 75.12 US$3,305,877
2020-06-25 2020-06-24 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
2,395 -0.1%
70.24
US$168,225 		2,395 -0.1% 70.24 US$168,225
2020-06-25 2020-06-24 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
1,600 -0.1%
69.29
US$110,865 		1,600 -0.1% 69.29 US$110,865
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
835 -0.0%
75.18
US$62,779 		835 -0.0% 75.18 US$62,779
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
63,257 -2.3%
74.60
US$4,719,257 		63,257 -2.3% 74.60 US$4,719,257
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
24,084 -0.9%
73.72
US$1,775,369 		24,084 -0.9% 73.72 US$1,775,369
2020-06-25 2020-06-23 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
4,296 -92.6%
75.05
US$322,431 		4,296 -92.6% 75.05 US$322,431
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
13,467 -0.5%
72.70
US$979,027 		13,467 -0.5% 72.70 US$979,027
2020-06-22 2020-06-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
49,132 -1.8%
73.64
US$3,618,012 		49,132 -1.8% 73.64 US$3,618,012
2020-06-22 2020-06-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
20,659 -0.7%
72.91
US$1,506,202 		20,659 -0.7% 72.91 US$1,506,202
2020-06-22 2020-06-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
10,540 -0.4%
72.01
US$758,961 		10,540 -0.4% 72.01 US$758,961
2020-06-22 2020-06-19 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
986 -74.3%
75.07
US$74,016 		986 -74.3% 75.07 US$74,016
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
428 -0.0%
75.22
US$32,193 		428 -0.0% 75.22 US$32,193
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
22,584 -0.8%
73.78
US$1,666,268 		22,584 -0.8% 73.78 US$1,666,268
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
12,157 -0.4%
72.93
US$886,619 		12,157 -0.4% 72.93 US$886,619
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
21,798 -0.8%
71.98
US$1,568,935 		21,798 -0.8% 71.98 US$1,568,935
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
58,238 -2.0%
70.91
US$4,129,855 		58,238 -2.0% 70.91 US$4,129,855
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
26,814 -0.9%
70.10
US$1,879,793 		26,814 -0.9% 70.10 US$1,879,793
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
22,012 -0.7%
69.01
US$1,519,094 		22,012 -0.7% 69.01 US$1,519,094
2020-06-22 2020-06-18 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
1,400 -80.4%
76.05
US$106,467 		1,400 -80.4% 76.05 US$106,467
2020-06-22 2020-06-18 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
59,914 -97.2%
75.25
US$4,508,822 		59,914 -97.2% 75.25 US$4,508,822
2020-06-18 2020-06-17 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
400 -9.9%
70.20
US$28,081 		400 -9.9% 70.20 US$28,081
2020-06-17 2020-06-17 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
24,000 -86.8%
70.20
US$1,684,870 		24,000 -86.8% 70.20 US$1,684,870
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
300 -0.0%
69.42
US$20,825 		300 -0.0% 69.42 US$20,825
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
25,208 -3.9%
68.73
US$1,732,458 		25,208 -3.9% 68.73 US$1,732,458
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
31,920 -4.7%
67.90
US$2,167,515 		31,920 -4.7% 67.90 US$2,167,515
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
2,572 -0.4%
66.94
US$172,162 		2,572 -0.4% 66.94 US$172,162
2020-06-17 2020-06-15 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
15,797 -2.3%
68.10
US$1,075,801 		15,797 -2.3% 68.10 US$1,075,801
2020-06-17 2020-06-15 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
18,703 -2.6%
67.51
US$1,262,557 		18,703 -2.6% 67.51 US$1,262,557
2020-06-17 2020-06-15 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
34,336 -4.5%
66.05
US$2,267,872 		34,336 -4.5% 66.05 US$2,267,872
Explore more

More insider trading research around Biohaven Pharmaceutical Holding Company Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America